The FDA gave the green light to Boston Scientific’s first-of-its-kind electric pulse system designed to treat pain without the use of opioids. https://www.fiercebiotech.com/medtech/fda-clears-boston-scientific-s-electric-pulse-system-for-non-opioid-pain-management Roche said that the EU approved Ocrevus for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis, a form of the neurological disease that previously was without an approved medicine. https://www.reuters.com/article/us-roche-ocrevus/roches-star-ms-medicine-ocrevus-wins-eu-approval-idUSKBN1F10JN[…]